NumFin

Idera Pharmaceuticals, Inc.

Sembol: IDRA

NASDAQ

0.425

USD

Bugünkü piyasa fiyatı

  • -97.1145

    F/K Oranı

  • 7.8442

    PEG Oranı

  • 26.50M

    MRK Kapağı

  • 0.00%

    DIV Verimi

Idera Pharmaceuticals, Inc. (IDRA) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Idera Pharmaceuticals, Inc. (IDRA). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

Idera Pharmaceuticals, Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

65.441232.537.7
42.8
71.4
112.6
109
60.2
41.2
29.4
10.1
24.6
34.6
31.7
55.6
23.7
38.2
8.4
14.4
13.7
19.2
31.8
3.5
2.6
5.6
2.2
16.4
5.3

balance-sheet.row.short-term-investments

0004.5
2.8
0
0
28.3
33.6
21.3
3.1
0
0
17.6
6.3
10.4
11.2
13.6
7.4
9.4
6.1
14.6
10.9
2
0
0
0
3.8
0

balance-sheet.row.net-receivables

8.384.200
0
0
0
0
0
0
0
0
0
0
4.5
0.5
0.6
0.4
0.2
0.3
0.2
0.4
0.3
0.3
1.2
1.2
0.5
0
0

balance-sheet.row.inventory

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

5.351.61.53.6
3.5
1.4
4
2
3.1
1.2
0.9
0.2
0.3
1
1
0.9
0.7
0.4
0.5
0.3
0.1
0.2
0.1
0.1
0.1
0.1
1
2.1
0.9

balance-sheet.row.total-current-assets

79.1617.93441.4
46.3
72.8
116.6
111
63.2
42.4
30.3
10.3
24.8
35.6
37.3
57
25
39
9
15
14
19.8
32.2
3.9
3.9
6.9
3.7
18.5
6.2

balance-sheet.row.property-plant-equipment-net

2.270.50.81
1.2
0.2
1.5
1.9
1.7
1.3
0.1
0.2
0.5
0.9
1.4
1.8
2
0.6
0.4
0.4
0.4
0.5
0.1
0.1
6.4
8.8
19.2
15.6
9.1

balance-sheet.row.goodwill

25.6611.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

201.6771.600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

227.3382.700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
27
7.3
6.2
0
0
0
8.5
0
0
0
0
0
0
941.1
0
0
0
0
0
0
1.7

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0.8200.10.1
0.1
0
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.6
0.7
0.9
0.5
0
0
-940.1
0
6
1.6
0.9
12.1
7.4
2.6

balance-sheet.row.total-non-current-assets

230.4383.20.81
1.2
0.2
1.8
2.2
29
9
6.6
0.5
0.8
1.2
10.4
2.4
2.7
1.5
0.9
0.4
0.4
1.5
0.1
6.1
8
9.6
31.3
23
13.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

309.59101.134.942.4
47.5
73
118.4
113.2
92.3
51.4
36.9
10.8
25.6
36.9
47.6
59.4
27.7
40.5
10
15.4
14.4
21.2
32.3
10
11.9
16.5
35.1
41.5
19.6

balance-sheet.row.account-payables

15.525.20.60.3
0.5
1.1
1.3
0.6
1.2
2.5
0.9
1.1
1.2
1.8
1.2
1.3
1.2
1.2
0.5
0.4
0.7
0.8
0.5
1.1
1.6
2.4
8.1
4.1
2.1

balance-sheet.row.short-term-debt

0.920.20.20.2
0.2
0
0.2
0.3
0.3
0.1
0
0
0
0
0
0
0.3
0
0
0
1.3
0
3.4
6
6.1
6.1
7.9
1.3
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

1.420.30.50.8
0.9
0
0
0.2
0.5
0.7
0
0
0
0
0
0
0.9
5
5
0
0
1.3
1.3
9.4
7.8
1.8
53.3
9
1.1

Deferred Revenue Non Current

0000
0
0
0
0.2
1.3
0
0
0
0
0
0.1
12.2
9.9
15249.6
1229.5
523.7
651.2
363.4
26129.7
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

10.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

46.81164.16.5
53.9
7.9
8
7.4
4.3
4.5
3.5
3
4.9
1.8
0.9
1.2
1.7
0.9
1.3
1.3
1.1
0.8
-3097.6
1.1
2.5
4.1
11.9
4.3
3.9

balance-sheet.row.total-non-current-liabilities

142.9540.80.5126.5
4.1
0
0.6
0.5
1.9
1
0
0.1
7.5
0.2
0.3
12.4
10.9
20.3
6.3
0.8
0.7
1.7
27.4
9.4
7.8
1.8
53.3
9
1.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

2.330.60.80.9
1.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

206.2162.25.4133.6
58.7
9
10.7
9.9
8.7
8
4.4
4.2
13.6
3.8
14.5
37.2
20
28.3
10.3
2.6
3.9
3.8
32.3
17.5
18
14.3
81.1
18.7
7.2

balance-sheet.row.preferred-stock

55.234.300
0
0
0
0
0
0
11
9.6
5.9
0
0
0
0
0
0
0
0
0
6.4
0
0
0
0
0
0

balance-sheet.row.common-stock

0.1200.10
0
0
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-3032.5-758.8-735.5-833.6
-720.9
-664.4
-604.5
-538.5
-500.1
-451.5
-412.9
-394.7
-375.4
-351.6
-333.7
-341.2
-342.7
-329.5
-313
-299.3
-283.9
-261.1
-273.9
-260.2
-253.2
-238.4
-218.7
-149.2
-102.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.02000
-0.8
-0.7
0
0
-0.1
0
0
-3.2
0
0
0
0
0
0
-0.1
0
0
0
-5.3
-5.3
-14.7
-13.8
-11.1
-6.6
-4.2

balance-sheet.row.other-total-stockholders-equity

3053.47736.4764.9742.3
710.5
729
712
641.7
583.7
494.9
434.3
394.8
381.5
384.7
366.8
363.4
350.4
341.7
312.6
312
294.4
278.6
272.7
257.9
261.8
254.5
183.7
178.6
118.9

balance-sheet.row.total-stockholders-equity

76.2711.829.5-91.2
-11.2
64
107.7
103.3
83.6
43.4
32.5
6.6
12
33.1
33.1
22.2
7.7
12.2
-0.3
12.8
10.5
17.4
0
-7.5
-6.1
2.2
-46
22.9
12.4

balance-sheet.row.total-liabilities-and-stockholders-equity

282.487434.942.4
47.5
73
118.4
113.2
92.3
51.4
36.9
10.8
25.6
36.9
47.6
59.4
27.7
40.5
10
15.4
14.4
21.2
32.3
10
11.9
16.5
35.1
41.5
19.6

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

76.2711.829.5-91.2
-11.2
64
107.7
103.3
83.6
43.4
32.5
6.6
12
33.1
33.1
22.2
7.7
12.2
-0.3
12.8
10.5
17.4
0
-7.5
-6.1
2.2
-46
22.9
12.4

balance-sheet.row.total-liabilities-and-total-equity

282.48---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0004.5
2.8
0
0
28.3
60.6
28.6
9.3
0
0
17.6
14.7
10.4
11.2
13.6
7.4
9.4
6.1
15588.5
10.9
2
0
0
0
3.8
1.7

balance-sheet.row.total-debt

2.330.60.80.9
1.1
0
0.2
0.5
0.8
0.9
0
0
0
0
0
0
1.2
5
5
0
1.3
1.3
4.7
15.4
13.9
7.9
61.2
10.3
1.6

balance-sheet.row.net-debt

-63.1-11.5-31.8-32.3
-39
-71.4
-112.4
-80.2
-25.8
-19.1
-26.3
-10.1
-24.6
-17
-25.4
-45.1
-11.4
-19.6
4.1
-5
-6.3
-3.2
-16.2
13.8
11.3
2.2
58.9
-2.3
-3.7

Nakit Akış Tablosu

Idera Pharmaceuticals, Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

cash-flows.row.net-income

-41.05-23.498.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
17
-5.3
-2.9
-10.5
-17.1
-69.5
-46.9
-34.5
-25.6

cash-flows.row.depreciation-and-amortization

0.01000.1
0.1
0.4
0.7
0.7
0.5
0.2
0.1
0.3
0.5
0.5
0.6
0.6
0.3
0.4
0.3
0.3
0.3
0.6
0.2
0.8
2.5
4.3
4.5
2.4
2
1.1

cash-flows.row.deferred-income-tax

-0.27-6.300
0
0
0
0
0
0
0
0
0
0
0
0
-1.6
-924.5
-99.7
-542.7
1297.4
1297.4
-1850.2
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

02.22.53.6
3.8
5.7
10.7
6.8
5.4
4.3
1.4
2.1
2.8
3.7
3.1
0
1.6
924.5
99.7
542.7
-1297.4
-1297.4
1850.2
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-0.860.30.4-1.1
-3.3
1.3
-1
1.9
-1.2
2.5
-0.6
-2.4
0.8
-6.1
-26.9
18.4
-5.1
17.4
2.6
-0.3
0.2
-28.6
11.9
-6.5
-1.3
-1.2
12.3
2.7
0.2
2.3

cash-flows.row.account-receivables

2-2.300
0
0
0
0
0
0
0
0
0
4.5
0
0
-0.2
0
117.2
203.4
-131.4
-131.4
-243.4
0
0
0
0
0
0
0

cash-flows.row.inventory

0000
0
0
0
0
0
0
0
0
0
0.1
0
0
-0.3
0
-58.3
-356.4
-24
-59.6
734.4
0
0
0
0
0
0
0

cash-flows.row.account-payables

-2.742.5-1.8-1.6
-1.1
-0.9
1.7
2
-1.7
2.8
0.1
-2.4
0.2
1.4
0
0
0.9
-251.3
-61.3
139.6
144.9
144.9
-506.4
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

1.7-0.32.10.5
-2.2
2.2
-2.7
0
0.5
-0.3
-0.7
0.1
0.6
-12.2
-26.9
18.4
-5.5
268.8
5
13.2
10.7
17.6
27.3
-6.5
-1.3
-1.2
12.3
2.7
0.2
0

cash-flows.row.other-non-cash-items

9.522.7-125.676.3
11.3
0.6
0.2
0.7
0.9
0.3
0.2
-0.7
0.5
0.3
0
3
2.2
1.2
0.2
-0.6
2.4
0
6.3
0.8
0.7
-8.6
1.5
-0.4
-0.2
0.8

cash-flows.row.net-cash-provided-by-operating-activities

-29.78000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0000
0
-0.1
-0.2
-0.4
-0.7
-1.1
0
0
0
-0.1
-0.1
-0.4
-1.6
-0.1
-0.2
-0.1
-0.1
-0.4
-0.1
0
0
-0.5
-7.5
-8.9
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-14080
403.6
-6396.4
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

000-12.2
-44.5
0
0
-2.9
-63.1
-23.6
-9.3
-1
-1
-10.3
-14.8
-23
-50.5
-26.8
-19.9
-18.6
-17.7
-16
-13.7
-2
0
0
0
-7.5
0
0

cash-flows.row.sales-maturities-of-investments

004.510.5
42.1
0
28.3
34.7
30.4
4.1
0
18.6
18.6
7.2
10.4
23.6
53
20.6
21.9
15.2
29.4
10.9
20.2
0
0
0
3.8
0
0
0

cash-flows.row.other-investing-activites

5.485.500
0
0.3
0
0
0
0
0
0.1
0.1
0.1
0.1
0
0
-0.6
0
14080
-403.6
6396.4
0
11.6
0
6.2
0
0.4
-6.6
-5.1

cash-flows.row.net-cash-used-for-investing-activites

5.485.54.5-1.7
-2.4
0.2
28.1
31.4
-33.4
-20.6
-9.3
17.6
17.6
-3.1
-4.3
0.2
0.9
-6.9
1.8
-3.5
11.7
-5.5
6.5
9.6
0
5.7
-3.7
-16
-6.6
-5.1

cash-flows.row.debt-repayment

000-0.2
0
-0.2
-0.3
-0.3
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7.3
-1.6
-0.4
0
0

cash-flows.row.common-stock-issued

000.228.8
15.4
0
53.8
49
80.6
37.1
40.2
0
0
14.1
0
10
1.8
27.9
0.1
15.6
13.1
0.5
0.7
0.2
1.5
6.9
0
55.4
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
-5339.5
-5.3
0
0
0
0
0
0
0
41.9
19.8

cash-flows.row.dividends-paid

0000
0
0
0
0
0
-0.8
-1.1
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-1.58-1.519.30.1
0.1
10.4
5.7
2.2
2.5
9.3
3.5
6
9.1
0.1
0.3
-1.2
1.1
0
4.6
5338.2
0
-0.4
-1
-3
4.1
20.8
46
10.6
-0.8
1.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-1.58-1.519.428.7
15.5
10.2
59.2
50.9
83
45.6
42.7
5.4
9.1
14.2
0.2
8.8
2.9
27.9
4.7
14.3
7.8
0.1
-0.3
-2.8
5.6
20.4
44.4
65.5
41.1
21.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
-17.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-25.88-20.5-0.7-6.8
-31.4
-41.5
32
54.1
6.6
-6.3
16.2
-14.5
7.6
-8.5
-19.7
32.6
-12
23.6
-4
-2.6
5.1
-16.4
19.4
-1
-3
3.4
-10.4
7.3
1.9
-5.4

cash-flows.row.cash-at-end-of-period

65.441232.533.2
40
71.4
112.6
80.7
26.6
20
26.3
10.1
24.6
17
25.5
45.2
12.6
24.6
1
5
7.6
4.5
20.9
1.5
2.6
5.6
2.2
12.6
1.9
66.1

cash-flows.row.cash-at-beginning-of-period

91.3132.533.240
71.4
112.9
80.7
26.6
20
26.3
10.1
24.6
17
25.5
45.2
12.6
24.6
1
5
7.6
2.5
20.9
1.5
2.6
5.6
2.2
12.6
5.3
0
71.4

cash-flows.row.operating-cash-flow

-29.78-24.5-24.6-33.8
-44.5
-51.9
-55.3
-28.2
-43
-31.3
-17.1
-19.9
-19.2
-19.6
-15.6
23.6
-15.8
2.6
-10.5
-13.3
-14.4
-11
13.1
-7.8
-8.6
-22.7
-51.1
-42.1
-32.6
-21.4

cash-flows.row.capital-expenditure

0000
0
-0.1
-0.2
-0.4
-0.7
-1.1
0
0
0
-0.1
-0.1
-0.4
-1.6
-0.1
-0.2
-0.1
-0.1
-0.4
-0.1
0
0
-0.5
-7.5
-8.9
0
0

cash-flows.row.free-cash-flow

-29.78-24.5-24.6-33.8
-44.5
-52
-55.5
-28.6
-43.7
-32.4
-17.1
-19.9
-19.2
-19.6
-15.7
23.2
-17.4
2.5
-10.8
-13.4
-14.4
-11.4
13
-7.8
-8.6
-23.1
-58.7
-51
-32.6
-21.4

Gelir Tablosu Satırı

Idera Pharmaceuticals, Inc.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin IDRA brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

0000
1.4
0.7
0.9
16.2
0.2
0.1
0
0.1
0.1
16.1
34.5
26.4
8
2.4
2.5
0.9
0.9
30.3
0.8
0.3
7
4.5
3.9
4
1.4
1.2

income-statement-row.row.cost-of-revenue

5.67000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.8
-2.5
0
0
0
0
0

income-statement-row.row.gross-profit

-5.67000
1.4
0.7
0.9
16.2
0.2
0.1
0
0.1
0.1
16.1
34.5
26.4
8
2.4
2.5
0.9
0.9
30.3
0.8
1.1
9.5
4.5
3.9
4
1.4
1.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

15.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

14.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

28.558.31.30
0.2
4.4
0
0
0
0
0
0
0
0
0
0
0
0
99.7
0
542.7
6719.5
-4.1
0.8
2.5
0
0
0
0
0

income-statement-row.row.operating-expenses

51.5832.727.736.7
47.3
57.3
67.4
55
49.1
38.8
18.2
20
25.9
34.1
27.1
25.9
22.7
19
16.3
13.9
18.3
13.6
7.4
7.6
19.3
27.5
57.9
50.7
35.8
26.7

income-statement-row.row.cost-and-expenses

57.2532.727.736.7
47.3
57.3
67.4
55
49.1
38.8
18.2
20
25.9
34.1
27.1
25.9
22.7
19
16.3
13.9
18.3
13.6
7.4
6.8
16.8
27.5
57.9
50.7
35.8
26.7

income-statement-row.row.interest-income

0000.2
1.1
1.1
0.6
0.4
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0.6
0.2
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.020.200
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0.1
0.1
0.4
0.3
0
0.1
0.2
1.3
2.2
0
0
0
0
-0.2
-0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.02-0.20-76
-10.4
1.1
0.5
0.4
0.3
0.1
-0.1
0.7
2.1
0
0.1
1
1.5
0
0.1
0.2
0.2
-0.2
0.5
0.1
0
0
-11
0
-0.2
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

28.558.31.30
0.2
4.4
0
0
0
0
0
0
0
0
0
0
0
0
99.7
0
542.7
6719.5
-4.1
0.8
2.5
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-0.02-0.20-76
-10.4
1.1
0.5
0.4
0.3
0.1
-0.1
0.7
2.1
0
0.1
1
1.5
0
0.1
0.2
0.2
-0.2
0.5
0.1
0
0
-11
0
-0.2
-0.1

income-statement-row.row.interest-expense

0.020.200
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0.1
0.1
0.4
0.3
0
0.1
0.2
1.3
2.2
0
0
0
0
-0.2
-0.1

income-statement-row.row.depreciation-and-amortization

1.711.700.1
0.1
0.4
0.7
0.7
0.5
0.2
0.1
0.3
0.5
0.5
0.6
0.6
0.3
0.4
0.3
0.3
0.3
0.6
0.2
0.8
2.5
4.3
4.5
2.4
2
1.1

income-statement-row.row.ebitda-caps

-45.91---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-47.62-29.598.1-36.7
-46.1
-61
-66.5
-38.8
-48.8
-38.8
-18.2
-19.9
-25.9
-18
7.4
0.5
-14.7
-16.6
-13.8
-12.9
-17.4
16.6
-6.6
-6.5
-9.8
-23
-64.9
-46.7
-34.4
-25.5

income-statement-row.row.income-before-tax

-47.64-29.798.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
16.5
-6.1
-6.5
0
0
-75.9
0
-34.5
-25.6

income-statement-row.row.income-tax-expense

-6.59-6.30-76
-10.4
1.1
0.5
0.4
0.4
0.1
-0.1
0.7
2.1
0
0
0
1.7
0
0.4
0.2
0.3
-0.5
0.5
2.2
0
0
-11
0
-0.3
-0.1

income-statement-row.row.net-income

-41.05-23.498.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
17
-5.3
-2.9
-10.5
-17.1
-69.5
-46.9
-34.5
-25.6
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
MRVI
Maravai LifeSciences Holdings, Inc..
7.7 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0361 USD
NASDAQ
T5O.DE
CytoTools AG.
0.488 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.09 NOK
OSL
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0774 USD
PNK

Sıkça Sorulan Sorular

Nedir Idera Pharmaceuticals, Inc. (IDRA) toplam varlıklar?

Idera Pharmaceuticals, Inc. (IDRA) toplam varlıklar 101107000.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir -49000.000'dur.

Firma kâr marjı nedir?

Firma kar marjı 58.878'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı -0.003'dur.

İşletme net kar marjı nedir?

Net kâr marjı 665.265'dir.

Firma toplam geliri nedir?

Toplam gelir 680.245'dur.

Nedir Idera Pharmaceuticals, Inc. (IDRA) net kar (net gelir)?

Net kar (net gelir) -23360000.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 560000.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 32680000.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 2118000.000'tir.